1993
DOI: 10.1097/00003246-199307000-00008
|View full text |Cite
|
Sign up to set email alerts
|

Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
41
1
6

Year Published

1996
1996
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 186 publications
(51 citation statements)
references
References 0 publications
3
41
1
6
Order By: Relevance
“…The increased survival was attributed to a preserved oxygen delivery with PLV, which deteriorated in the non-PFC-treated control group. The authors also partially confirm previous experiences with PLV in animal models of acute lung injury (ALI), which have shown that: 1) Higher doses of PFC lead to higher levels of oxygenation [7]. This is suggested to result from dose-dependent recruitment of collapsed atelectatic alveoli by PFC fluid.…”
supporting
confidence: 84%
“…The increased survival was attributed to a preserved oxygen delivery with PLV, which deteriorated in the non-PFC-treated control group. The authors also partially confirm previous experiences with PLV in animal models of acute lung injury (ALI), which have shown that: 1) Higher doses of PFC lead to higher levels of oxygenation [7]. This is suggested to result from dose-dependent recruitment of collapsed atelectatic alveoli by PFC fluid.…”
supporting
confidence: 84%
“…It has been shown that in surfactant-deficient animal lungs PLV provides adequate gas exchange as long as a sufficient amount of PFC is present in the lungs [10 -13]. The present group has demonstrated that higher doses of PFC lead to higher levels of oxygenation in animals suffering from acute respiratory failure as a result of dose-dependent recruitment of collapsed atelectatic alveoli by PFC [10,11]. It is also known that oxygenation deteriorates over time if no additional doses of PFC are instilled; this is attributed to evaporation of PFC which will cause affected alveoli to collapse [10,11].…”
Section: Discussionmentioning
confidence: 67%
“…The PFC used in this study (Liquivent1, Alliance Pharmaceutical, San Diego, CA, USA) is insoluble in water, has a specific gravity of 1.918 g?cm -1 at 25uC, a surface tension of 18.1 dynes?cm -1 , vapour pressure of 3.6 torr (0.5 kPa) at 20uC and 10.5 torr (1.4 kPa) at 37uC, an oxygen solubility of 53 mL?100 mL -1 and CO 2 solubility of 210 mL?100 mL -1 at 37uC, at 1 atmosphere pressure [10,11]. The groups PFC10 and PFC20 received a single dose of PFC intratracheally.…”
Section: Treatment With Perfluorocarbonsmentioning
confidence: 99%
See 1 more Smart Citation
“…On the other hand, a shorter PFD aerosolization time was needed to improve lung mechanics; C dyn significantly had already improved in the PFC aerosol group by 30 min after the initiation of the therapy. On the basis of our bench studies (14,21), at 30 min of therapy, a PFD dose of ~3-3.5 ml/kg would have effectively reached the lung, which corresponds to the minimal dose of PFC to significantly improve C dyn according to Tütüncu et al (9).…”
Section: Discussionmentioning
confidence: 79%